Hafez, Mohamed MAbdel-Hafez, Lina Jamil MJamil, LubnaIbrahim, Sherine M2021-09-172021-09-179/17/2021https://doi.org/10.5114/aoms/140451http://repository.msa.edu.eg/xmlui/handle/123456789/4701Background: Hepatitis C is considered one of the most popular diseases in Egypt. We aim is to clarify the association between Cluster of Differentiation 24 (CD24) polymorphism, Talin-1 gene expression, and the prevalence of hepatocellular carcinoma in Egyptian Hepatitis C virus patients. Methods: The link between CD24 polymorphism rs8734 and the prevalence of hepatocellular carcinoma was assessed between 200 control subjects and 400 hepatitis C virus patients (HCV), patients were classified as follows; 200 patients with HCV and 200 with HCV and hepatocellular carcinoma (HCC) by histopathological assessment and PCR-restriction fragment length polymorphism (PCR-RFLP). Results: The hepatitis c patients with HCC showed a significant increase in alpha - fetoprotein (AFP) and Talin-1 gene expression compared to patients with HCV as well as in healthy volunteers. Furthermore, the frequencies of CD 24 170 CT/TT genotype were significantly higher in HCV patients without complications (60%) when compared to CC genotype (40%) (OR= 6 at X2= 14.41, P = 0.0007), and in HCV with HCC patients (90%) when compared to CC genotype (10%) (OR= 36 at X2= 14.41, P = 0.0007). Conclusion: These data suggest that CD24 genetic polymorphism rs8734 and Talin-1 gene expression may be a significant determinant for the prevalence of hepatocellular carcinoma in HCV patients.en-USHCVhepatocellular carcinomaSNPCD24Alpha fetoproteinTalin-1alpha-fetoprotein.Articlehttps://doi.org/10.5114/aoms/140451